Citi Pharma (KAR:CPHL) Interest Expense : ₨ Mil (TTM As of . 20)

View and export this data going back to 2021. Start your Free Trial

What is Citi Pharma Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Citi Pharma's interest expense for the six months ended in . 20 was ₨ 0.00 Mil. Citi Pharma does not have enough years/quarters to calculate its interest expense for the trailing twelve months (TTM) ended in . 20.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Citi Pharma's Operating Income for the six months ended in . 20 was ₨ 0.00 Mil. Citi Pharma's Interest Expense for the six months ended in . 20 was ₨ 0.00 Mil. Citi Pharma did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Citi Pharma Interest Expense Historical Data

The historical data trend for Citi Pharma's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Citi Pharma Interest Expense Chart

Citi Pharma Annual Data

Trend

Interest Expense

Citi Pharma Semi-Annual Data

Interest Expense

Citi Pharma Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Citi Pharma (KAR:CPHL) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Citi Pharma's Interest Expense for the six months ended in . 20 was ₨0.00 Mil. Its Operating Income for the six months ended in . 20 was ₨0.00 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in . 20 was ₨0.00 Mil.

Citi Pharma's Interest Coverage for the quarter that ended in . 20 is calculated as

Citi Pharma had no long-term debt ⁽¹⁾.

The higher the ratio, the stronger the company's financial strength is.

Citi Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Citi Pharma Ltd (KAR:CPHL) » Definitions » Interest Expense

Traded in Other Exchanges

N/A

Address

588 Q Block, Johar Town, Lahore, PB, PAK

Website

http://www.citipharma.com.pk

Citi Pharma Ltd is engaged in the manufacturing and sale of pharmaceuticals, medical chemicals and botanical products. Its departments include Active Pharma Ingredients (API) and Formulations. Some of its products include Askprol C Tab, Lenon Tab, Recoz Tab, Cingol Tab among others.

Citi Pharma Headlines

No Headlines